Reviva Pharmaceuticals Holdings Inc (RVPH)
2.87
+0.06
(+2.17%)
USD |
NASDAQ |
May 08, 16:00
2.87
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Enterprise Value: 55.06M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 55.06M |
| May 06, 2024 | 58.71M |
| May 03, 2024 | 65.97M |
| May 02, 2024 | 65.41M |
| May 01, 2024 | 67.65M |
| April 30, 2024 | 62.06M |
| April 29, 2024 | 57.60M |
| April 26, 2024 | 60.11M |
| April 25, 2024 | 59.83M |
| April 24, 2024 | 60.95M |
| April 23, 2024 | 62.06M |
| April 22, 2024 | 62.90M |
| April 19, 2024 | 60.95M |
| April 18, 2024 | 60.95M |
| April 17, 2024 | 65.97M |
| April 16, 2024 | 69.60M |
| April 15, 2024 | 73.79M |
| April 12, 2024 | 79.65M |
| April 11, 2024 | 82.44M |
| April 10, 2024 | 79.37M |
| April 09, 2024 | 78.26M |
| April 08, 2024 | 77.98M |
| April 05, 2024 | 76.58M |
| April 04, 2024 | 77.70M |
| April 03, 2024 | 78.81M |
| Date | Value |
|---|---|
| April 02, 2024 | 73.51M |
| April 01, 2024 | 71.00M |
| March 28, 2024 | 82.16M |
| March 27, 2024 | 85.52M |
| March 26, 2024 | 83.56M |
| March 25, 2024 | 64.30M |
| March 22, 2024 | 57.32M |
| March 21, 2024 | 53.69M |
| March 20, 2024 | 54.80M |
| March 19, 2024 | 55.92M |
| March 18, 2024 | 62.62M |
| March 15, 2024 | 64.58M |
| March 14, 2024 | 57.32M |
| March 13, 2024 | 64.30M |
| March 12, 2024 | 63.46M |
| March 11, 2024 | 69.32M |
| March 08, 2024 | 74.35M |
| March 07, 2024 | 81.61M |
| March 06, 2024 | 83.28M |
| March 05, 2024 | 82.44M |
| March 04, 2024 | 82.72M |
| March 01, 2024 | 82.72M |
| February 29, 2024 | 83.00M |
| February 28, 2024 | 84.68M |
| February 27, 2024 | 88.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-10.34M
Minimum
Aug 10 2022
164.28M
Maximum
May 05 2023
53.98M
Average
59.83M
Median
Apr 25 2024
Enterprise Value Benchmarks
| AbbVie Inc | 343.01B |
| ABVC BioPharma Inc | 12.27M |
| Sutro Biopharma Inc | -45.03M |
| Flora Growth Corp | 13.72M |
| Journey Medical Corp | 56.29M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.724M |
| Total Expenses (Quarterly) | 9.988M |
| EPS Diluted (Quarterly) | -0.35 |
| Earnings Yield | -57.14% |